Skip to main content

Table 6 Logistic regression analysis of influencing factors of abnormal ABI values

From: The association between time in the glucose target range and abnormal ankle-brachial index: a cross-sectional analysis

 

Abnormal ABI

 

OR

95% CI

P value

Model 1

 TIR

0.979

0.967–0.990

 < 0.001

Model 2

 TIR

0.981

0.965–0.997

0.020

 HbA1C

0.876

0.732–1.049

0.150

Model 3

 TIR

0.978

0.960–0.996

0.016

 HbA1C

0.913

0.757–1.102

0.345

 SD

0.842

0.577–1.228

0.371

Model 4

 TIR

0.977

0.960–0.995

0.013

 HbA1C

0.908

0.752–1.098

0.319

 MAGE

0.860

0.715–1.035

0.110

Model 5

 TIR

0.980

0.964–0.996

0.016

 HbA1C

0.927

0.767–1.119

0.428

 CV

0.025

 < 0.001–1.763

0.089

Model 6

 TIR

0.972

0.949–0.995

0.016

 HbA1C

0.895

0.739–1.084

0.256

 ADDR

0.968

0.925–1.013

0.161

Model 7

 TIR

0.976

0.957–0.995

0.015

 HbA1C

0.896

0.735–1.091

0.274

 MODD

0.752

0.500–1.132

0.172

Model 8

 TIR

0.975

0.953–0.998

0.032

 HbA1C

0.900

0.750–1.080

0.256

 M value

0.982

0.935–1.032

0.476

  1. aTIR: time in range; HbA1C: hemoglobin A1C; SD: standard deviation; MAGE: mean amplitude of glucose excursions; CV: coefficient of variation; ADDR: average daily risk range; MODD: mean of daily differences; OR: odds ratio; CI: confidence interval
  2. bConfounding factors were not adjusted in Model 1. Model 2 was adjusted for age, diabetes duration, gender, blood pressure, lipid profiles, Scr, UREA, ACR, BMI, and HbA1C (%). Model 3 was adjusted for variables as in Model 2 and for SD. Model 4 was adjusted for variables as in Model 2 and for MAGE; Model 5 was adjusted for variables as in Model 2 and for CV. Model 6 was adjusted for variables as in Model 2 and for ADDR; Model 7 was adjusted for variables as in Model 2 and for MODD; Model 8 was adjusted for variables as in Model 2 and for M values
  3. The bolded values in the table highlight results with P value < 0.05
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840